Company / Working Capital per Share
Allogene Therapeutics, Inc. Working Capital per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.06
FY2025
5-year range
$1.06 / $3.04
FY2021-FY2025
Trend
-33.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $3.04 in FY2022 to $1.06 in FY2025.
Based on SEC 10-K filings.
1.06 in FY2025 with a 3-year CAGR of -29.6%.
Declined from $2.94 to $1.06 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -29.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Allogene Therapeutics, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 33.2% year-over-year.
- Peak working capital per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.06 | -33.2% |
| FY2024 | $1.59 | -46.0% |
| FY2023 | $2.94 | -3.2% |
| FY2022 | $3.04 | +0.8% |
| FY2021 | $3.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026